StockData
biote Corp. logo

biote Corp. (BTMD) stock

BTMDNasdaqMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 8/3065% below fair value
$0.89−0.10 (-10.51%)

Close on Nov 18, 2026Market cap $31.83MP/E 8.9Yield –

biote shares outstanding

Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.

biote's shares outstanding was 29M at Jun 30, 2026. For fiscal 2025 it was 37M, up 7.0% from the year before.

Annual shares outstanding

PeriodPeriod endValueChange
FY2025Dec 31, 202537M+7.0%
FY2024Dec 31, 202434M+33.3%
FY2023Dec 31, 202326M+219.0%
FY2022Dec 31, 20228M–

Quarterly shares outstanding

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 202629M-9.8%
Q1 FY2026Mar 31, 202636M-2.6%
Q4 FY2025Dec 31, 202536M-3.6%
Q3 FY2025Sep 30, 202537M+13.8%
Q2 FY2025Jun 30, 202532M-4.0%
Q1 FY2025Mar 31, 202537M+6.7%
Q4 FY2024Dec 31, 202437M+9.7%
Q3 FY2024Sep 30, 202432M+3.9%
Q2 FY2024Jun 30, 202433M+59.7%
Q1 FY2024Mar 31, 202435M+96.9%
Q4 FY2023Dec 31, 202334M+260.6%
Q3 FY2023Sep 30, 202331M+308.2%
Q2 FY2023Jun 30, 202321M+173.4%
Q1 FY2023Mar 31, 202318M–
Q4 FY2022Dec 31, 20229M–
Q3 FY2022Sep 30, 20228M–
Q2 FY2022Jun 30, 20228M–

More biote figures

See a number that looks wrong?